Literature DB >> 8353250

Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin.

C Watanakunakorn1, R Patel.   

Abstract

Patients with enterococcal bacteremia due to strains with and without high-level gentamicin resistance (HLGR; MIC, > 2,000 mg/L) were compared. Between 1986 and 1991, there were 178 episodes of enterococcal bacteremia: 47 and 131 episodes, respectively, due to enterococcal strains with and without HLGR. Sixty-two, 57, and 59 episodes, respectively, were in patients with transient bacteremia (a single positive blood culture), bacteremia (two or more positive blood cultures), and polymicrobial bacteremia. Nosocomial bacteremia accounted for 61.7% and 51.1% of episodes due to strains with and without HLGR, respectively. All isolates were strains of Enterococcus faecalis except for 13 strains of Enterococcus faecium, 4 of Enterococcus avium, and 3 of Enterococcus durans. Although the mortality was slightly higher among patients infected with strains with HLGR than among those infected with strains without HLGR (38.3% vs. 30.5%, respectively), there was no statistical difference. The mortality rate was adversely affected by old age (P < .01) and rapidly and ultimately fatal underlying conditions (P < .001). The addition of gentamicin to the treatment regimens had no effect on mortality.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353250     DOI: 10.1093/clinids/17.1.74

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  [Antibiotic resistance of enterococci in Germany].

Authors:  C Wallrauch; E Elsner; D Milatovic; J Cremer; I Braveny
Journal:  Med Klin (Munich)       Date:  1997-08-15

2.  Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas.

Authors:  F J Caballero-Granado; J M Cisneros; R Luque; M Torres-Tortosa; F Gamboa; F Díez; J L Villanueva; R Pérez-Cano; J Pasquau; D Merino; A Menchero; D Mora; M A López-Ruz; A Vergara
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Enterococcal bacteremia in a tertiary care centre in Winnipeg.

Authors:  T A Madani; A Kabani; P Orr; L Nicolle
Journal:  Can J Infect Dis       Date:  1999-01

Review 4.  Bacteraemia in the very old. Features and treatment.

Authors:  L Leibovici
Journal:  Drugs Aging       Date:  1995-06       Impact factor: 3.923

5.  Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.

Authors:  S J McBride; A Upton; S A Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-15       Impact factor: 3.267

6.  Clinical Features and Rate of Infective Endocarditis in Non-Faecalis and Non-faecium Enterococcal Bacteremia.

Authors:  Hee-Chang Jang; Wan Beom Park; Hong Bin Kim; Eui-Chong Kim; Myoung-Don Oh
Journal:  Chonnam Med J       Date:  2011-08-31

7.  Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.

Authors:  Hee-Chang Jang; Shinwon Lee; Kyoung-Ho Song; Jae Hyun Jeon; Wan Beom Park; Sang-Won Park; Hong Bin Kim; Nam Joong Kim; Eui-Chong Kim; Myoung-Don Oh; Kang Won Choe
Journal:  J Korean Med Sci       Date:  2009-12-29       Impact factor: 2.153

Review 8.  Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management.

Authors:  Tristan O'Driscoll; Christopher W Crank
Journal:  Infect Drug Resist       Date:  2015-07-24       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.